Interpretable machine learning-guided single-cell mapping deciphers multi-lineage pancreatic dysregulation in type 2 diabetes.

backgroundPancreatic cellular heterogeneity is fundamental to systemic metabolic regulation, yet its pathological remodeling in diabetes remains poorly characterized.

methodsWe integrated single-cell RNA sequencing with machine learning frameworks to decode pancreatic heterogeneity. Novel tools included PanSubPred (two-stage feature selection/XGBoost classifier) for multi-lineage annotation and PSC-Stat (XGBoost/Gini optimization) for stellate cell activation analysis.

resultsBy establishing PanSubPred, we systematically decoded pancreatic cellular diversity, identifying 64 cell-type-specific markers (38 novel) that maintained cross-dataset accuracy (AUC > 0.970) even after excluding known canonical markers. Building on this annotation precision, we developed PSC-Stat to quantify stellate cell activation dynamics, revealing their progressive activation from diabetes to pancreatic cancer (activated/quiescent ratio: control: 1.44 ± 1.02, diabetes: 4.72 ± 4.01, pancreatic cancer: 18.67 ± 18.70). Diabetes reorganized intercellular communication into ductal-centric hubs via FGF7-FGFR2/3, EFNB3-EPHB2/4/6 and EFNA5-EPHA2 axes, from which we derived a 15-gene signature for diabetic ductal cells (AUC = 0.846). Beta cell heterogeneity analysis uncovered diabetes-associated depletion of mature insulin-secretory clusters (INS + NKX6-1+), expansion of immature (CD81 + RBP4+) and endoplasmic reticulum stress-adapted subtypes (DDIT3 + HSPA5+). Moreover, non-beta lineages exhibited parallel dysfunction: acinar cells shifted toward inflammatory states (CCL2 + CXCL17+), while ductal cells adopted secretory phenotypes (MUC1 + CFTR+).

conclusionsThis study presents a machine learning-based single-cell framework that systematically maps pancreatic cellular alterations in diabetes. The identified novel signatures, stellate activation dynamics, and beta cell maturation trajectories may serve as potential targets for diabetic management and pancreatic cancer risk stratification.